Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.


Overview | Financials
Company Name Onconova Therapeutics, Inc.
Symbol ONTX
Currency USD
Price 0.995
Market Cap 20,904,684
Dividend Yield 0%
52-week-range 0.551 - 1.45
Industry Biotechnology
Sector Healthcare
CEO Dr. Steven M. Fruchtman M.D.
Website https://www.onconova.com

An error occurred while fetching data.

About Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in

Related Stocks

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.


22.93 USD

Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.


4.06 USD

Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.


0.478 USD

Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.


1.185 USD

Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.


3.031 USD

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.


2.95 USD


Numbers are in millions USD

Numbers are in millions USD